SCHEMBL24258523

SCHEMBL24258523

C=C(CC(C)(C)C)N1CCCc2ccc(-c3c(C)ccc(Cl)c3C(F)F)cc2C1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR142 Q7Z601 1/20 0.35
RIPK1 Q13546 3/20 0.34
CREBBP Q92793 1/20 0.33
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19657619 0.83 RIPK1 (0.37) RIPK1HDAC6
SCHEMBL19657912 0.76 CREBBP (0.41) RIPK1CREBBPHDAC6
SCHEMBL24258489 0.73 CREBBP (0.56) CREBBP
SCHEMBL19657828 0.69 CREBBP (0.36) RIPK1CREBBP
SCHEMBL24258486 0.69 CREBBP (0.61) CREBBP
SCHEMBL19644123 0.66 CREBBP (0.53) GPR142RIPK1CREBBP
SCHEMBL27347680 0.65 MAPT (0.41) HDAC6
SCHEMBL24258482 0.64 RIPK1 (0.45) RIPK1CREBBPHDAC6
SCHEMBL19657386 0.64 CREBBP (0.36) RIPK1CREBBPHDAC6
SCHEMBL19657616 0.62 HDAC6 (0.32) RIPK1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464270-B1 HETEROCYCLIC INHIBITORS OF CBP/EP300 AND THEIR USE IN THE TREATMENT OF CANCER GENENTECH INC (US) 2022-02-23 EP disclosed